Vor Bio to Participate in Upcoming Investor Conferences
04 Marzo 2024 - 2:00PM
Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering
company, today announced that it will participate in the following
upcoming investor conferences:
Barclays 26th Annual Global Healthcare
ConferenceFireside Chat: Tuesday, March 12, 2024 at 4:35
pm ET Location: Miami, FL
A live webcast and archived replay of the fireside chat will be
available on the investors section of www.vorbio.com.
H.C. Wainwright 2nd Annual Cell Therapy Virtual
ConferenceFireside Chat: Tuesday, March 26, 2024 at 2:30
pm ET Location: Virtual
About Vor BioVor Bio is a clinical-stage cell
and genome engineering company that aims to change the standard of
care for patients with blood cancers by engineering hematopoietic
stem cells to enable targeted therapies post-transplant. For more
information, visit: www.vorbio.com.
Contact:Media & InvestorsSarah Spencer +1
857-242-6076sspencer@vorbio.com
Grafico Azioni Vor Biopharma (NASDAQ:VOR)
Storico
Da Nov 2024 a Dic 2024
Grafico Azioni Vor Biopharma (NASDAQ:VOR)
Storico
Da Dic 2023 a Dic 2024
